Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Appointed director
Quarterly results
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 8-K Quarterly results
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results -Conference Call and Webcast Today, August 7, 2023 at 4:30 p.m. ET"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.1% stake in Arrowhead Pharmaceuticals Inc.
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 8-K Quarterly results
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/20/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.7% stake in Arrowhead Pharmaceuticals Inc.
02/08/2023 SC 13G/A STATE STREET CORP reports a 5.6% stake in AMENDED FILING ARROWHEAD PHARMACEUTICALS INC
02/06/2023 8-K Quarterly results
02/06/2023 10-Q Quarterly Report for the period ended December 31, 2022
01/30/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "3.1 1 SECOND AMENDED AND RESTATED BYLAWS OF ARROWHEAD PHARMACEUTICALS, INC. ARTICLE I STOCKHOLDERS"
01/30/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
01/26/2023 SC 13G/A BlackRock Inc. reports a 12% stake in ARROWHEAD PHARMACEUTICALS INC
01/20/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
01/20/2023 SC 13G BlackRock Inc. reports a 12% stake in ARROWHEAD PHARMACEUTICALS INC
12/08/2022 8-K Quarterly results
12/02/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
11/28/2022 8-K Quarterly results
11/28/2022 10-K Annual Report for the period ended September 30, 2022
11/10/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
09/30/2022 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results –Conference Call and Webcast Today, August 4, 2022 at 4:30 p.m. ET"
07/19/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/10/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy